Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Munch-a-Biotech Today -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (876)	8/9/2000 8:30:11 AM
From: scott_jiminez	Read Replies (1) \| Respond to of 3158

Nigel - an interesting munch since Genovo was Ariad's mistress. No mention of ARIA. Another interesting omission is the name of James Wilson, the ex-director of the Institute for Human Gene Therapy (IHGT). This is the program at Penn that crashed and burned in the wake of Jesse Gelsinger's demise. Genovo was founded by Wilson; he had orchestrated numerous inseparable links between the IHGT and (privately held) Genovo that were juuust a wee bit questionable. Wilson's behavior brought scathing reprimands from the NIH and forced Penn to permanently cease all clinical trials at the IHGT (and to rewrite its ethics standards....). James Wilson, founder of Genovo, former boy-wonder of gene therapy, not mentioned in the press release. Hmmmmmmmmmm. And oh the irony: in the period immediately following Gelsinger's death, companies such as TGEN and AVGN were casting aspersions like tobacco juice at Wilson's approach and reagents, claiming 'That could never happen to US, we use better, safer, more advanced vectors' blah blah blah. Don't like the weather? Just wait.